nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—migraine—Prednisone—psoriatic arthritis	0.89	1	CpDpCtD
Naratriptan—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000207	0.00188	CcSEcCtD
Naratriptan—Bradycardia—Prednisone—psoriatic arthritis	0.000207	0.00188	CcSEcCtD
Naratriptan—Alopecia—Betamethasone—psoriatic arthritis	0.000206	0.00187	CcSEcCtD
Naratriptan—Alopecia—Dexamethasone—psoriatic arthritis	0.000206	0.00187	CcSEcCtD
Naratriptan—Discomfort—Prednisolone—psoriatic arthritis	0.000205	0.00186	CcSEcCtD
Naratriptan—Haemoglobin—Prednisone—psoriatic arthritis	0.000204	0.00185	CcSEcCtD
Naratriptan—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000204	0.00184	CcSEcCtD
Naratriptan—Haemorrhage—Prednisone—psoriatic arthritis	0.000203	0.00184	CcSEcCtD
Naratriptan—Erythema—Betamethasone—psoriatic arthritis	0.000203	0.00184	CcSEcCtD
Naratriptan—Erythema—Dexamethasone—psoriatic arthritis	0.000203	0.00184	CcSEcCtD
Naratriptan—Hallucination—Prednisone—psoriatic arthritis	0.000202	0.00183	CcSEcCtD
Naratriptan—Malaise—Triamcinolone—psoriatic arthritis	0.000202	0.00183	CcSEcCtD
Naratriptan—Malaise—Methylprednisolone—psoriatic arthritis	0.000202	0.00183	CcSEcCtD
Naratriptan—Vertigo—Triamcinolone—psoriatic arthritis	0.000201	0.00182	CcSEcCtD
Naratriptan—Syncope—Triamcinolone—psoriatic arthritis	0.000201	0.00182	CcSEcCtD
Naratriptan—Vertigo—Methylprednisolone—psoriatic arthritis	0.000201	0.00182	CcSEcCtD
Naratriptan—Syncope—Methylprednisolone—psoriatic arthritis	0.0002	0.00182	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000199	0.0018	CcSEcCtD
Naratriptan—Oedema—Prednisolone—psoriatic arthritis	0.000199	0.0018	CcSEcCtD
Naratriptan—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000197	0.00178	CcSEcCtD
Naratriptan—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000196	0.00178	CcSEcCtD
Naratriptan—Shock—Prednisolone—psoriatic arthritis	0.000196	0.00177	CcSEcCtD
Naratriptan—Cough—Triamcinolone—psoriatic arthritis	0.000196	0.00177	CcSEcCtD
Naratriptan—Convulsion—Triamcinolone—psoriatic arthritis	0.000194	0.00176	CcSEcCtD
Naratriptan—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000194	0.00176	CcSEcCtD
Naratriptan—Convulsion—Methylprednisolone—psoriatic arthritis	0.000194	0.00175	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000192	0.00174	CcSEcCtD
Naratriptan—Myalgia—Triamcinolone—psoriatic arthritis	0.000191	0.00173	CcSEcCtD
Naratriptan—Pneumonia—Methotrexate—psoriatic arthritis	0.00019	0.00172	CcSEcCtD
Naratriptan—Myalgia—Methylprednisolone—psoriatic arthritis	0.00019	0.00172	CcSEcCtD
Naratriptan—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00019	0.00172	CcSEcCtD
Naratriptan—Anxiety—Methylprednisolone—psoriatic arthritis	0.00019	0.00172	CcSEcCtD
Naratriptan—Drowsiness—Methotrexate—psoriatic arthritis	0.000189	0.00171	CcSEcCtD
Naratriptan—Depression—Methotrexate—psoriatic arthritis	0.000189	0.00171	CcSEcCtD
Naratriptan—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000189	0.00171	CcSEcCtD
Naratriptan—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000189	0.00171	CcSEcCtD
Naratriptan—Discomfort—Triamcinolone—psoriatic arthritis	0.000188	0.00171	CcSEcCtD
Naratriptan—Discomfort—Methylprednisolone—psoriatic arthritis	0.000188	0.0017	CcSEcCtD
Naratriptan—Dry mouth—Triamcinolone—psoriatic arthritis	0.000187	0.00169	CcSEcCtD
Naratriptan—Angiopathy—Prednisone—psoriatic arthritis	0.000185	0.00167	CcSEcCtD
Naratriptan—Confusional state—Methylprednisolone—psoriatic arthritis	0.000184	0.00167	CcSEcCtD
Naratriptan—Immune system disorder—Prednisone—psoriatic arthritis	0.000184	0.00166	CcSEcCtD
Naratriptan—Malaise—Betamethasone—psoriatic arthritis	0.000183	0.00166	CcSEcCtD
Naratriptan—Malaise—Dexamethasone—psoriatic arthritis	0.000183	0.00166	CcSEcCtD
Naratriptan—Oedema—Triamcinolone—psoriatic arthritis	0.000183	0.00166	CcSEcCtD
Naratriptan—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000183	0.00166	CcSEcCtD
Naratriptan—Vertigo—Betamethasone—psoriatic arthritis	0.000183	0.00165	CcSEcCtD
Naratriptan—Vertigo—Dexamethasone—psoriatic arthritis	0.000183	0.00165	CcSEcCtD
Naratriptan—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000182	0.00165	CcSEcCtD
Naratriptan—Syncope—Dexamethasone—psoriatic arthritis	0.000182	0.00165	CcSEcCtD
Naratriptan—Syncope—Betamethasone—psoriatic arthritis	0.000182	0.00165	CcSEcCtD
Naratriptan—Arrhythmia—Prednisone—psoriatic arthritis	0.000182	0.00165	CcSEcCtD
Naratriptan—Infection—Triamcinolone—psoriatic arthritis	0.000182	0.00165	CcSEcCtD
Naratriptan—Sweating—Methotrexate—psoriatic arthritis	0.000182	0.00164	CcSEcCtD
Naratriptan—Infection—Methylprednisolone—psoriatic arthritis	0.000181	0.00164	CcSEcCtD
Naratriptan—Shock—Triamcinolone—psoriatic arthritis	0.00018	0.00163	CcSEcCtD
Naratriptan—Alopecia—Prednisone—psoriatic arthritis	0.00018	0.00163	CcSEcCtD
Naratriptan—Shock—Methylprednisolone—psoriatic arthritis	0.00018	0.00163	CcSEcCtD
Naratriptan—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000179	0.00162	CcSEcCtD
Naratriptan—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000179	0.00162	CcSEcCtD
Naratriptan—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000179	0.00162	CcSEcCtD
Naratriptan—Paraesthesia—Prednisolone—psoriatic arthritis	0.000179	0.00162	CcSEcCtD
Naratriptan—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000177	0.00161	CcSEcCtD
Naratriptan—Erythema—Prednisone—psoriatic arthritis	0.000177	0.0016	CcSEcCtD
Naratriptan—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000177	0.0016	CcSEcCtD
Naratriptan—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000176	0.0016	CcSEcCtD
Naratriptan—Convulsion—Dexamethasone—psoriatic arthritis	0.000176	0.0016	CcSEcCtD
Naratriptan—Convulsion—Betamethasone—psoriatic arthritis	0.000176	0.0016	CcSEcCtD
Naratriptan—Myalgia—Dexamethasone—psoriatic arthritis	0.000173	0.00157	CcSEcCtD
Naratriptan—Myalgia—Betamethasone—psoriatic arthritis	0.000173	0.00157	CcSEcCtD
Naratriptan—Anxiety—Betamethasone—psoriatic arthritis	0.000172	0.00156	CcSEcCtD
Naratriptan—Anxiety—Dexamethasone—psoriatic arthritis	0.000172	0.00156	CcSEcCtD
Naratriptan—Discomfort—Dexamethasone—psoriatic arthritis	0.000171	0.00155	CcSEcCtD
Naratriptan—Discomfort—Betamethasone—psoriatic arthritis	0.000171	0.00155	CcSEcCtD
Naratriptan—Haemoglobin—Methotrexate—psoriatic arthritis	0.000171	0.00155	CcSEcCtD
Naratriptan—Hypotension—Methylprednisolone—psoriatic arthritis	0.00017	0.00154	CcSEcCtD
Naratriptan—Pain—Prednisolone—psoriatic arthritis	0.00017	0.00154	CcSEcCtD
Naratriptan—Haemorrhage—Methotrexate—psoriatic arthritis	0.00017	0.00154	CcSEcCtD
Naratriptan—Vision blurred—Prednisone—psoriatic arthritis	0.000167	0.00151	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000167	0.00151	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000166	0.00151	CcSEcCtD
Naratriptan—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000166	0.0015	CcSEcCtD
Naratriptan—Oedema—Betamethasone—psoriatic arthritis	0.000166	0.0015	CcSEcCtD
Naratriptan—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000166	0.0015	CcSEcCtD
Naratriptan—Oedema—Dexamethasone—psoriatic arthritis	0.000166	0.0015	CcSEcCtD
Naratriptan—Infection—Dexamethasone—psoriatic arthritis	0.000165	0.00149	CcSEcCtD
Naratriptan—Infection—Betamethasone—psoriatic arthritis	0.000165	0.00149	CcSEcCtD
Naratriptan—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000164	0.00149	CcSEcCtD
Naratriptan—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000164	0.00149	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000164	0.00148	CcSEcCtD
Naratriptan—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000164	0.00148	CcSEcCtD
Naratriptan—Anaemia—Prednisone—psoriatic arthritis	0.000164	0.00148	CcSEcCtD
Naratriptan—Shock—Betamethasone—psoriatic arthritis	0.000163	0.00148	CcSEcCtD
Naratriptan—Shock—Dexamethasone—psoriatic arthritis	0.000163	0.00148	CcSEcCtD
Naratriptan—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000163	0.00148	CcSEcCtD
Naratriptan—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000163	0.00147	CcSEcCtD
Naratriptan—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000163	0.00147	CcSEcCtD
Naratriptan—Agitation—Prednisone—psoriatic arthritis	0.000163	0.00147	CcSEcCtD
Naratriptan—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000162	0.00147	CcSEcCtD
Naratriptan—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000162	0.00147	CcSEcCtD
Naratriptan—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00016	0.00145	CcSEcCtD
Naratriptan—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00016	0.00145	CcSEcCtD
Naratriptan—Malaise—Prednisone—psoriatic arthritis	0.00016	0.00145	CcSEcCtD
Naratriptan—Vertigo—Prednisone—psoriatic arthritis	0.000159	0.00144	CcSEcCtD
Naratriptan—Syncope—Prednisone—psoriatic arthritis	0.000159	0.00144	CcSEcCtD
Naratriptan—Tinnitus—Methotrexate—psoriatic arthritis	0.000158	0.00144	CcSEcCtD
Naratriptan—Urticaria—Prednisolone—psoriatic arthritis	0.000158	0.00143	CcSEcCtD
Naratriptan—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000158	0.00143	CcSEcCtD
Naratriptan—Fatigue—Triamcinolone—psoriatic arthritis	0.000158	0.00143	CcSEcCtD
Naratriptan—Fatigue—Methylprednisolone—psoriatic arthritis	0.000157	0.00142	CcSEcCtD
Naratriptan—Pain—Triamcinolone—psoriatic arthritis	0.000156	0.00142	CcSEcCtD
Naratriptan—Loss of consciousness—Prednisone—psoriatic arthritis	0.000156	0.00141	CcSEcCtD
Naratriptan—Hypotension—Dexamethasone—psoriatic arthritis	0.000155	0.0014	CcSEcCtD
Naratriptan—Hypotension—Betamethasone—psoriatic arthritis	0.000155	0.0014	CcSEcCtD
Naratriptan—Angiopathy—Methotrexate—psoriatic arthritis	0.000154	0.0014	CcSEcCtD
Naratriptan—Immune system disorder—Methotrexate—psoriatic arthritis	0.000154	0.00139	CcSEcCtD
Naratriptan—Convulsion—Prednisone—psoriatic arthritis	0.000153	0.00139	CcSEcCtD
Naratriptan—Chills—Methotrexate—psoriatic arthritis	0.000153	0.00138	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000151	0.00137	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000151	0.00137	CcSEcCtD
Naratriptan—Myalgia—Prednisone—psoriatic arthritis	0.000151	0.00137	CcSEcCtD
Naratriptan—Arthralgia—Prednisone—psoriatic arthritis	0.000151	0.00137	CcSEcCtD
Naratriptan—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000151	0.00136	CcSEcCtD
Naratriptan—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00015	0.00136	CcSEcCtD
Naratriptan—Anxiety—Prednisone—psoriatic arthritis	0.00015	0.00136	CcSEcCtD
Naratriptan—Alopecia—Methotrexate—psoriatic arthritis	0.00015	0.00136	CcSEcCtD
Naratriptan—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000149	0.00135	CcSEcCtD
Naratriptan—Paraesthesia—Betamethasone—psoriatic arthritis	0.000149	0.00135	CcSEcCtD
Naratriptan—Discomfort—Prednisone—psoriatic arthritis	0.000149	0.00135	CcSEcCtD
Naratriptan—Erythema—Methotrexate—psoriatic arthritis	0.000148	0.00134	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000146	0.00133	CcSEcCtD
Naratriptan—Urticaria—Triamcinolone—psoriatic arthritis	0.000145	0.00132	CcSEcCtD
Naratriptan—Urticaria—Methylprednisolone—psoriatic arthritis	0.000145	0.00131	CcSEcCtD
Naratriptan—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000145	0.00131	CcSEcCtD
Naratriptan—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000144	0.00131	CcSEcCtD
Naratriptan—Oedema—Prednisone—psoriatic arthritis	0.000144	0.00131	CcSEcCtD
Naratriptan—Infection—Prednisone—psoriatic arthritis	0.000144	0.0013	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000143	0.0013	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000143	0.0013	CcSEcCtD
Naratriptan—Fatigue—Betamethasone—psoriatic arthritis	0.000143	0.0013	CcSEcCtD
Naratriptan—Fatigue—Dexamethasone—psoriatic arthritis	0.000143	0.0013	CcSEcCtD
Naratriptan—Shock—Prednisone—psoriatic arthritis	0.000142	0.00129	CcSEcCtD
Naratriptan—Pain—Dexamethasone—psoriatic arthritis	0.000142	0.00129	CcSEcCtD
Naratriptan—Pain—Betamethasone—psoriatic arthritis	0.000142	0.00129	CcSEcCtD
Naratriptan—Nervous system disorder—Prednisone—psoriatic arthritis	0.000142	0.00128	CcSEcCtD
Naratriptan—Skin disorder—Prednisone—psoriatic arthritis	0.00014	0.00127	CcSEcCtD
Naratriptan—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00014	0.00127	CcSEcCtD
Naratriptan—Vision blurred—Methotrexate—psoriatic arthritis	0.000139	0.00126	CcSEcCtD
Naratriptan—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000137	0.00124	CcSEcCtD
Naratriptan—Anaemia—Methotrexate—psoriatic arthritis	0.000137	0.00124	CcSEcCtD
Naratriptan—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000137	0.00124	CcSEcCtD
Naratriptan—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000137	0.00124	CcSEcCtD
Naratriptan—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000135	0.00122	CcSEcCtD
Naratriptan—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000134	0.00122	CcSEcCtD
Naratriptan—Malaise—Methotrexate—psoriatic arthritis	0.000133	0.00121	CcSEcCtD
Naratriptan—Vertigo—Methotrexate—psoriatic arthritis	0.000133	0.0012	CcSEcCtD
Naratriptan—Urticaria—Betamethasone—psoriatic arthritis	0.000132	0.00119	CcSEcCtD
Naratriptan—Urticaria—Dexamethasone—psoriatic arthritis	0.000132	0.00119	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000132	0.00119	CcSEcCtD
Naratriptan—Dizziness—Prednisolone—psoriatic arthritis	0.000131	0.00119	CcSEcCtD
Naratriptan—Asthenia—Triamcinolone—psoriatic arthritis	0.000131	0.00119	CcSEcCtD
Naratriptan—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000131	0.00119	CcSEcCtD
Naratriptan—Body temperature increased—Betamethasone—psoriatic arthritis	0.000131	0.00119	CcSEcCtD
Naratriptan—Asthenia—Methylprednisolone—psoriatic arthritis	0.000131	0.00119	CcSEcCtD
Naratriptan—Paraesthesia—Prednisone—psoriatic arthritis	0.00013	0.00118	CcSEcCtD
Naratriptan—Pruritus—Triamcinolone—psoriatic arthritis	0.000129	0.00117	CcSEcCtD
Naratriptan—Cough—Methotrexate—psoriatic arthritis	0.000129	0.00117	CcSEcCtD
Naratriptan—Pruritus—Methylprednisolone—psoriatic arthritis	0.000129	0.00117	CcSEcCtD
Naratriptan—Convulsion—Methotrexate—psoriatic arthritis	0.000128	0.00116	CcSEcCtD
Naratriptan—Arthralgia—Methotrexate—psoriatic arthritis	0.000126	0.00114	CcSEcCtD
Naratriptan—Myalgia—Methotrexate—psoriatic arthritis	0.000126	0.00114	CcSEcCtD
Naratriptan—Rash—Prednisolone—psoriatic arthritis	0.000125	0.00114	CcSEcCtD
Naratriptan—Dermatitis—Prednisolone—psoriatic arthritis	0.000125	0.00113	CcSEcCtD
Naratriptan—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000125	0.00113	CcSEcCtD
Naratriptan—Fatigue—Prednisone—psoriatic arthritis	0.000125	0.00113	CcSEcCtD
Naratriptan—Headache—Prednisolone—psoriatic arthritis	0.000125	0.00113	CcSEcCtD
Naratriptan—Discomfort—Methotrexate—psoriatic arthritis	0.000124	0.00113	CcSEcCtD
Naratriptan—Constipation—Prednisone—psoriatic arthritis	0.000124	0.00112	CcSEcCtD
Naratriptan—Confusional state—Methotrexate—psoriatic arthritis	0.000122	0.0011	CcSEcCtD
Naratriptan—Dizziness—Triamcinolone—psoriatic arthritis	0.000121	0.0011	CcSEcCtD
Naratriptan—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000121	0.00109	CcSEcCtD
Naratriptan—Dizziness—Methylprednisolone—psoriatic arthritis	0.000121	0.00109	CcSEcCtD
Naratriptan—Infection—Methotrexate—psoriatic arthritis	0.00012	0.00109	CcSEcCtD
Naratriptan—Feeling abnormal—Prednisone—psoriatic arthritis	0.000119	0.00108	CcSEcCtD
Naratriptan—Asthenia—Betamethasone—psoriatic arthritis	0.000119	0.00108	CcSEcCtD
Naratriptan—Asthenia—Dexamethasone—psoriatic arthritis	0.000119	0.00108	CcSEcCtD
Naratriptan—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000118	0.00107	CcSEcCtD
Naratriptan—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000118	0.00107	CcSEcCtD
Naratriptan—Nausea—Prednisolone—psoriatic arthritis	0.000118	0.00107	CcSEcCtD
Naratriptan—Pruritus—Betamethasone—psoriatic arthritis	0.000117	0.00106	CcSEcCtD
Naratriptan—Pruritus—Dexamethasone—psoriatic arthritis	0.000117	0.00106	CcSEcCtD
Naratriptan—Skin disorder—Methotrexate—psoriatic arthritis	0.000117	0.00106	CcSEcCtD
Naratriptan—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000117	0.00106	CcSEcCtD
Naratriptan—Vomiting—Triamcinolone—psoriatic arthritis	0.000116	0.00105	CcSEcCtD
Naratriptan—Vomiting—Methylprednisolone—psoriatic arthritis	0.000116	0.00105	CcSEcCtD
Naratriptan—Rash—Triamcinolone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Dermatitis—Triamcinolone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Rash—Methylprednisolone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Urticaria—Prednisone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Headache—Triamcinolone—psoriatic arthritis	0.000115	0.00104	CcSEcCtD
Naratriptan—Headache—Methylprednisolone—psoriatic arthritis	0.000114	0.00104	CcSEcCtD
Naratriptan—Body temperature increased—Prednisone—psoriatic arthritis	0.000114	0.00103	CcSEcCtD
Naratriptan—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000114	0.00103	CcSEcCtD
Naratriptan—Diarrhoea—Betamethasone—psoriatic arthritis	0.000114	0.00103	CcSEcCtD
Naratriptan—Hypotension—Methotrexate—psoriatic arthritis	0.000113	0.00102	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00011	0.000996	CcSEcCtD
Naratriptan—Dizziness—Dexamethasone—psoriatic arthritis	0.00011	0.000994	CcSEcCtD
Naratriptan—Dizziness—Betamethasone—psoriatic arthritis	0.00011	0.000994	CcSEcCtD
Naratriptan—Nausea—Triamcinolone—psoriatic arthritis	0.000109	0.000984	CcSEcCtD
Naratriptan—Paraesthesia—Methotrexate—psoriatic arthritis	0.000108	0.000982	CcSEcCtD
Naratriptan—Nausea—Methylprednisolone—psoriatic arthritis	0.000108	0.000982	CcSEcCtD
Naratriptan—Dyspnoea—Methotrexate—psoriatic arthritis	0.000108	0.000975	CcSEcCtD
Naratriptan—Somnolence—Methotrexate—psoriatic arthritis	0.000107	0.000972	CcSEcCtD
Naratriptan—Hypersensitivity—Prednisone—psoriatic arthritis	0.000106	0.000964	CcSEcCtD
Naratriptan—Vomiting—Betamethasone—psoriatic arthritis	0.000105	0.000955	CcSEcCtD
Naratriptan—Vomiting—Dexamethasone—psoriatic arthritis	0.000105	0.000955	CcSEcCtD
Naratriptan—Rash—Dexamethasone—psoriatic arthritis	0.000105	0.000947	CcSEcCtD
Naratriptan—Rash—Betamethasone—psoriatic arthritis	0.000105	0.000947	CcSEcCtD
Naratriptan—Dermatitis—Betamethasone—psoriatic arthritis	0.000105	0.000947	CcSEcCtD
Naratriptan—Dermatitis—Dexamethasone—psoriatic arthritis	0.000105	0.000947	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000104	0.000944	CcSEcCtD
Naratriptan—Fatigue—Methotrexate—psoriatic arthritis	0.000104	0.000943	CcSEcCtD
Naratriptan—Headache—Dexamethasone—psoriatic arthritis	0.000104	0.000941	CcSEcCtD
Naratriptan—Headache—Betamethasone—psoriatic arthritis	0.000104	0.000941	CcSEcCtD
Naratriptan—Asthenia—Prednisone—psoriatic arthritis	0.000104	0.000939	CcSEcCtD
Naratriptan—Pain—Methotrexate—psoriatic arthritis	0.000103	0.000935	CcSEcCtD
Naratriptan—Pruritus—Prednisone—psoriatic arthritis	0.000102	0.000926	CcSEcCtD
Naratriptan—Feeling abnormal—Methotrexate—psoriatic arthritis	9.95e-05	0.000901	CcSEcCtD
Naratriptan—Diarrhoea—Prednisone—psoriatic arthritis	9.89e-05	0.000895	CcSEcCtD
Naratriptan—Nausea—Dexamethasone—psoriatic arthritis	9.86e-05	0.000893	CcSEcCtD
Naratriptan—Nausea—Betamethasone—psoriatic arthritis	9.86e-05	0.000893	CcSEcCtD
Naratriptan—Urticaria—Methotrexate—psoriatic arthritis	9.59e-05	0.000869	CcSEcCtD
Naratriptan—Dizziness—Prednisone—psoriatic arthritis	9.55e-05	0.000865	CcSEcCtD
Naratriptan—Body temperature increased—Methotrexate—psoriatic arthritis	9.55e-05	0.000865	CcSEcCtD
Naratriptan—Vomiting—Prednisone—psoriatic arthritis	9.19e-05	0.000832	CcSEcCtD
Naratriptan—Rash—Prednisone—psoriatic arthritis	9.11e-05	0.000825	CcSEcCtD
Naratriptan—Dermatitis—Prednisone—psoriatic arthritis	9.1e-05	0.000824	CcSEcCtD
Naratriptan—Headache—Prednisone—psoriatic arthritis	9.05e-05	0.00082	CcSEcCtD
Naratriptan—Hypersensitivity—Methotrexate—psoriatic arthritis	8.9e-05	0.000806	CcSEcCtD
Naratriptan—Asthenia—Methotrexate—psoriatic arthritis	8.66e-05	0.000785	CcSEcCtD
Naratriptan—Nausea—Prednisone—psoriatic arthritis	8.58e-05	0.000777	CcSEcCtD
Naratriptan—Pruritus—Methotrexate—psoriatic arthritis	8.54e-05	0.000774	CcSEcCtD
Naratriptan—Diarrhoea—Methotrexate—psoriatic arthritis	8.26e-05	0.000748	CcSEcCtD
Naratriptan—Dizziness—Methotrexate—psoriatic arthritis	7.99e-05	0.000723	CcSEcCtD
Naratriptan—Vomiting—Methotrexate—psoriatic arthritis	7.68e-05	0.000695	CcSEcCtD
Naratriptan—Rash—Methotrexate—psoriatic arthritis	7.61e-05	0.00069	CcSEcCtD
Naratriptan—Dermatitis—Methotrexate—psoriatic arthritis	7.61e-05	0.000689	CcSEcCtD
Naratriptan—Headache—Methotrexate—psoriatic arthritis	7.57e-05	0.000685	CcSEcCtD
Naratriptan—Nausea—Methotrexate—psoriatic arthritis	7.17e-05	0.00065	CcSEcCtD
